About this trial
Adapt and test the effectiveness of MBRP for substance use peer workers compared to a standard of care (referral to 12-step) control condition on substance use, relapse risk, and burnout among peers in a pilot hybrid type 1 trial.
The goal of this clinical trial is to learn if Mindfulness-Based Relapse Prevention can reduce substance use, relapse risk, and burnout among substance use peer workers. The objectives are to:
1. Identify the causes, consequences, and risk and protective factors for relapse among peer workers; 2. Identify peers' preferences related to MBRP content, structure, and delivery; 3. Adapt the MBRP intervention for peer workers; and 4. Assess the preliminary effectiveness and implementation outcomes of the adapted MBRP intervention.
Researchers will compare MBRP to referral to 12-step (standard of care) to see if MRBP works to reduce substance use, relapse risk, and burnout.
Participants will asked to:
* Participate in MBRP (8 weekly 2-hour virtual sessions) * Complete 4 surveys assessing well-being outcomes * Participate in 1 virtual interview about your experience
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Are > 18 years old
Fluent in English
Be currently employed in a substance use peer support role
At-risk for SUD relapse as measured by a craving score of >15 on the adapted Penn Alcohol Craving Scale
Disqualifiers
Have a cognitive impairment that jeopardizes informed consent
Actively suicidal or psychotic
Trial design
Parallel
Treatments tested in this trial
Mindfulness Based Relapse Prevention
BehavioralMBRP for peer workers consists of 8 weekly 2-hour virtual sessions.
Standard of Care
BehavioralReferral to 12-step programming
Treatment groups
Trial outcomes
Primary outcomes
Change from baseline in biologically verified substance use at 1, 3, and 6 months as measured by Saliva Drug Assays
Saliva drug assays detecting the presence or absence of commonly used substances. Results are reported as positive or negative for each substance tested, with negative results indicating a better outcome.
Change from baseline in self-reported substance use days at 1, 3, and 6 months as measured by the Timeline Follow-Back (TLFB)
A calendar-based interview assessing daily substance use over a specified recall period. Outcomes are reported as the number of days of substance use during the assessment period, with fewer days indicating a better outcome.
Change from baseline in relapse warning Signs at 1, 3, and 6 months as measured by the Advance Warning of Relapse (AWARE) Questionnaire
A 28-item; 7-point Likert-type scale assessing warning signs associated with relapse risk. Total scores range from 28 to 196, with higher scores indicating greater relapse risk (worse outcome).
Change from baseline in professional quality of life at 1, 3, and 6 months as measured by the Professional Quality of Life Scale (ProQOL)
A 30-item; 5-point Likert-type scale assessing professional quality of life across three 10-item subscales: Compassion Satisfaction, Burnout, and Secondary Traumatic Stress. Each subscale score ranges from 10 to 50. Higher Compassion Satisfaction scores indicate a better outcome, whereas higher Burnout and Secondary Traumatic Stress scores indicate worse outcomes.
Secondary outcomes
Change from baseline in the coping score assessed by the Brief-COPE measure at 6 months
A 28-item; 4-point Likert-type scale assessing coping strategies. The Brief COPE consists of 14 two-item subscales, each ranging from 2 to 8, with higher scores indicating greater use of that specific coping strategy. There is no overall total score.
Change from baseline in total score of emotion regulation assessed by the Difficulty in Emotion Regulation Scale (DERS) measure at 6 months
A 36-item; 5-point Likert-type scale assessing difficulties with emotion regulation. Total scores range from 36 to 180, with higher scores indicating greater difficulties in emotion regulation (worse outcome).
Change from baseline in total score of perceived stress assessed by the Perceived Stress Scale (PSS-10) measure at 6 months
A 10-item; 5-point Likert-type scale assessing perceived stress. Total scores range from 0 to 40, with higher scores indicating greater perceived stress (worse outcome).
Change from baseline in total score of trait mindfulness assessed by the Five Factor Mindfulness Questionnaire (FFMQ-15) measure at 6 months
A 15-item; 5-point Likert-type scale assessing trait mindfulness. Total scores range from 15 to 75, with higher scores indicating greater mindfulness (better outcome).
Other outcomes
Change from baseline in mean score of mental health assessed by the Behavior and Symptom Identification Scale (BASIS-24) measure at 6 months
A 24-item; 5-point Likert-type scale assessing mental health symptoms and functioning. Total scores range from 0 to 4 (calculated as the mean of completed items), with higher scores indicating greater psychiatric symptoms and functional difficulties (worse outcome).
Change from baseline in mean score of recovery capital assessed by the Multidimensional Inventory of Recovery Capital (MIRC) measure at 6 months
A 28-item; 4-point Likert-type scale assessing recovery capital across multiple domains. Total scores range from 28 to 112, with higher scores indicating greater recovery capital (better outcome).
Change from baseline in mean score of work engagement assessed by the Utrecht Work Engagement Scale (UWES-9) measure at 6 months
A 9-item; 7-point Likert-type scale assessing work engagement. Total scores range from 0 to 54 (or a mean score ranging from 0 to 6), with higher scores indicating greater work engagement (better outcome).
Sponsors and contacts
Click on the lead sponsor to view all of their trials.